Gilead Sciences, Inc. 13D and 13G filings for Leap Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-19 4:31 pm Purchase | 2024-04-10 | 13G | LEAP THERAPEUTICS INC LPTX | GILEAD SCIENCES, INC. GILD | 5,319,148 13.900% | 5,319,148 (New Position) | Filing |